Acute Myeloid Leukemia Treatment Market
1 Introduction to Research & Analysis Reports
1.1 Acute Myeloid Leukemia Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Acute Myeloid Leukemia Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Acute Myeloid Leukemia Treatment Overall Market Size
2.1 Global Acute Myeloid Leukemia Treatment Market Size: 2021 VS 2028
2.2 Global Acute Myeloid Leukemia Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Acute Myeloid Leukemia Treatment Players in Global Market
3.2 Top Global Acute Myeloid Leukemia Treatment Companies Ranked by Revenue
3.3 Global Acute Myeloid Leukemia Treatment Revenue by Companies
3.4 Top 3 and Top 5 Acute Myeloid Leukemia Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Acute Myeloid Leukemia Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Acute Myeloid Leukemia Treatment Players in Global Market
3.6.1 List of Global Tier 1 Acute Myeloid Leukemia Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Acute Myeloid Leukemia Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Acute Myeloid Leukemia Treatment Market Size Markets, 2021 & 2028
4.1.2 DC Regimen
4.1.3 AVD Regimen
4.1.4 VCD Regimen
4.2 By Type - Global Acute Myeloid Leukemia Treatment Revenue & Forecasts
4.2.1 By Type - Global Acute Myeloid Leukemia Treatment Revenue, 2017-2022
4.2.2 By Type - Global Acute Myeloid Leukemia Treatment Revenue, 2023-2028
4.2.3 By Type - Global Acute Myeloid Leukemia Treatment Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Acute Myeloid Leukemia Treatment Market Size, 2021 & 2028
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Others
5.2 By Application - Global Acute Myeloid Leukemia Treatment Revenue & Forecasts
5.2.1 By Application - Global Acute Myeloid Leukemia Treatment Revenue, 2017-2022
5.2.2 By Application - Global Acute Myeloid Leukemia Treatment Revenue, 2023-2028
5.2.3 By Application - Global Acute Myeloid Leukemia Treatment Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Acute Myeloid Leukemia Treatment Market Size, 2021 & 2028
6.2 By Region - Global Acute Myeloid Leukemia Treatment Revenue & Forecasts
6.2.1 By Region - Global Acute Myeloid Leukemia Treatment Revenue, 2017-2022
6.2.2 By Region - Global Acute Myeloid Leukemia Treatment Revenue, 2023-2028
6.2.3 By Region - Global Acute Myeloid Leukemia Treatment Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Acute Myeloid Leukemia Treatment Revenue, 2017-2028
6.3.2 US Acute Myeloid Leukemia Treatment Market Size, 2017-2028
6.3.3 Canada Acute Myeloid Leukemia Treatment Market Size, 2017-2028
6.3.4 Mexico Acute Myeloid Leukemia Treatment Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Acute Myeloid Leukemia Treatment Revenue, 2017-2028
6.4.2 Germany Acute Myeloid Leukemia Treatment Market Size, 2017-2028
6.4.3 France Acute Myeloid Leukemia Treatment Market Size, 2017-2028
6.4.4 U.K. Acute Myeloid Leukemia Treatment Market Size, 2017-2028
6.4.5 Italy Acute Myeloid Leukemia Treatment Market Size, 2017-2028
6.4.6 Russia Acute Myeloid Leukemia Treatment Market Size, 2017-2028
6.4.7 Nordic Countries Acute Myeloid Leukemia Treatment Market Size, 2017-2028
6.4.8 Benelux Acute Myeloid Leukemia Treatment Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Acute Myeloid Leukemia Treatment Revenue, 2017-2028
6.5.2 China Acute Myeloid Leukemia Treatment Market Size, 2017-2028
6.5.3 Japan Acute Myeloid Leukemia Treatment Market Size, 2017-2028
6.5.4 South Korea Acute Myeloid Leukemia Treatment Market Size, 2017-2028
6.5.5 Southeast Asia Acute Myeloid Leukemia Treatment Market Size, 2017-2028
6.5.6 India Acute Myeloid Leukemia Treatment Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Acute Myeloid Leukemia Treatment Revenue, 2017-2028
6.6.2 Brazil Acute Myeloid Leukemia Treatment Market Size, 2017-2028
6.6.3 Argentina Acute Myeloid Leukemia Treatment Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Acute Myeloid Leukemia Treatment Revenue, 2017-2028
6.7.2 Turkey Acute Myeloid Leukemia Treatment Market Size, 2017-2028
6.7.3 Israel Acute Myeloid Leukemia Treatment Market Size, 2017-2028
6.7.4 Saudi Arabia Acute Myeloid Leukemia Treatment Market Size, 2017-2028
6.7.5 UAE Acute Myeloid Leukemia Treatment Market Size, 2017-2028
7 Players Profiles
7.1 Ambit Biosciences Corporation
7.1.1 Ambit Biosciences Corporation Corporate Summary
7.1.2 Ambit Biosciences Corporation Business Overview
7.1.3 Ambit Biosciences Corporation Acute Myeloid Leukemia Treatment Major Product Offerings
7.1.4 Ambit Biosciences Corporation Acute Myeloid Leukemia Treatment Revenue in Global Market (2017-2022)
7.1.5 Ambit Biosciences Corporation Key News
7.2 Celgene Corporation
7.2.1 Celgene Corporation Corporate Summary
7.2.2 Celgene Corporation Business Overview
7.2.3 Celgene Corporation Acute Myeloid Leukemia Treatment Major Product Offerings
7.2.4 Celgene Corporation Acute Myeloid Leukemia Treatment Revenue in Global Market (2017-2022)
7.2.5 Celgene Corporation Key News
7.3 Cephalon
7.3.1 Cephalon Corporate Summary
7.3.2 Cephalon Business Overview
7.3.3 Cephalon Acute Myeloid Leukemia Treatment Major Product Offerings
7.3.4 Cephalon Acute Myeloid Leukemia Treatment Revenue in Global Market (2017-2022)
7.3.5 Cephalon Key News
7.4 Clavis Pharma
7.4.1 Clavis Pharma Corporate Summary
7.4.2 Clavis Pharma Business Overview
7.4.3 Clavis Pharma Acute Myeloid Leukemia Treatment Major Product Offerings
7.4.4 Clavis Pharma Acute Myeloid Leukemia Treatment Revenue in Global Market (2017-2022)
7.4.5 Clavis Pharma Key News
7.5 Eisai
7.5.1 Eisai Corporate Summary
7.5.2 Eisai Business Overview
7.5.3 Eisai Acute Myeloid Leukemia Treatment Major Product Offerings
7.5.4 Eisai Acute Myeloid Leukemia Treatment Revenue in Global Market (2017-2022)
7.5.5 Eisai Key News
7.6 Genzyme Corporation
7.6.1 Genzyme Corporation Corporate Summary
7.6.2 Genzyme Corporation Business Overview
7.6.3 Genzyme Corporation Acute Myeloid Leukemia Treatment Major Product Offerings
7.6.4 Genzyme Corporation Acute Myeloid Leukemia Treatment Revenue in Global Market (2017-2022)
7.6.5 Genzyme Corporation Key News
7.7 Sunesis Pharmaceuticals
7.7.1 Sunesis Pharmaceuticals Corporate Summary
7.7.2 Sunesis Pharmaceuticals Business Overview
7.7.3 Sunesis Pharmaceuticals Acute Myeloid Leukemia Treatment Major Product Offerings
7.7.4 Sunesis Pharmaceuticals Acute Myeloid Leukemia Treatment Revenue in Global Market (2017-2022)
7.7.5 Sunesis Pharmaceuticals Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Acute Myeloid Leukemia Treatment Market Opportunities & Trends in Global Market
Table 2. Acute Myeloid Leukemia Treatment Market Drivers in Global Market
Table 3. Acute Myeloid Leukemia Treatment Market Restraints in Global Market
Table 4. Key Players of Acute Myeloid Leukemia Treatment in Global Market
Table 5. Top Acute Myeloid Leukemia Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Acute Myeloid Leukemia Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Acute Myeloid Leukemia Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Acute Myeloid Leukemia Treatment Product Type
Table 9. List of Global Tier 1 Acute Myeloid Leukemia Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Acute Myeloid Leukemia Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Acute Myeloid Leukemia Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Acute Myeloid Leukemia Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Acute Myeloid Leukemia Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Acute Myeloid Leukemia Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Acute Myeloid Leukemia Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Acute Myeloid Leukemia Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Acute Myeloid Leukemia Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Acute Myeloid Leukemia Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Acute Myeloid Leukemia Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Acute Myeloid Leukemia Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Acute Myeloid Leukemia Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Acute Myeloid Leukemia Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Acute Myeloid Leukemia Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Acute Myeloid Leukemia Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Acute Myeloid Leukemia Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Acute Myeloid Leukemia Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Acute Myeloid Leukemia Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Acute Myeloid Leukemia Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Acute Myeloid Leukemia Treatment Revenue, (US$, Mn), 2023-2028
Table 30. Ambit Biosciences Corporation Corporate Summary
Table 31. Ambit Biosciences Corporation Acute Myeloid Leukemia Treatment Product Offerings
Table 32. Ambit Biosciences Corporation Acute Myeloid Leukemia Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Celgene Corporation Corporate Summary
Table 34. Celgene Corporation Acute Myeloid Leukemia Treatment Product Offerings
Table 35. Celgene Corporation Acute Myeloid Leukemia Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Cephalon Corporate Summary
Table 37. Cephalon Acute Myeloid Leukemia Treatment Product Offerings
Table 38. Cephalon Acute Myeloid Leukemia Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Clavis Pharma Corporate Summary
Table 40. Clavis Pharma Acute Myeloid Leukemia Treatment Product Offerings
Table 41. Clavis Pharma Acute Myeloid Leukemia Treatment Revenue (US$, Mn), (2017-2022)
Table 42. Eisai Corporate Summary
Table 43. Eisai Acute Myeloid Leukemia Treatment Product Offerings
Table 44. Eisai Acute Myeloid Leukemia Treatment Revenue (US$, Mn), (2017-2022)
Table 45. Genzyme Corporation Corporate Summary
Table 46. Genzyme Corporation Acute Myeloid Leukemia Treatment Product Offerings
Table 47. Genzyme Corporation Acute Myeloid Leukemia Treatment Revenue (US$, Mn), (2017-2022)
Table 48. Sunesis Pharmaceuticals Corporate Summary
Table 49. Sunesis Pharmaceuticals Acute Myeloid Leukemia Treatment Product Offerings
Table 50. Sunesis Pharmaceuticals Acute Myeloid Leukemia Treatment Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Acute Myeloid Leukemia Treatment Segment by Type in 2021
Figure 2. Acute Myeloid Leukemia Treatment Segment by Application in 2021
Figure 3. Global Acute Myeloid Leukemia Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Acute Myeloid Leukemia Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Acute Myeloid Leukemia Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Acute Myeloid Leukemia Treatment Revenue in 2021
Figure 8. By Type - Global Acute Myeloid Leukemia Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Acute Myeloid Leukemia Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Acute Myeloid Leukemia Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Acute Myeloid Leukemia Treatment Revenue Market Share, 2017-2028
Figure 12. US Acute Myeloid Leukemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Acute Myeloid Leukemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Acute Myeloid Leukemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Acute Myeloid Leukemia Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Acute Myeloid Leukemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Acute Myeloid Leukemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Acute Myeloid Leukemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Acute Myeloid Leukemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Acute Myeloid Leukemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Acute Myeloid Leukemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Acute Myeloid Leukemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Acute Myeloid Leukemia Treatment Revenue Market Share, 2017-2028
Figure 24. China Acute Myeloid Leukemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Acute Myeloid Leukemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Acute Myeloid Leukemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Acute Myeloid Leukemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Acute Myeloid Leukemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Acute Myeloid Leukemia Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Acute Myeloid Leukemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Acute Myeloid Leukemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Acute Myeloid Leukemia Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Acute Myeloid Leukemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Acute Myeloid Leukemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Acute Myeloid Leukemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Acute Myeloid Leukemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. Ambit Biosciences Corporation Acute Myeloid Leukemia Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Celgene Corporation Acute Myeloid Leukemia Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Cephalon Acute Myeloid Leukemia Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Clavis Pharma Acute Myeloid Leukemia Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Eisai Acute Myeloid Leukemia Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Genzyme Corporation Acute Myeloid Leukemia Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Sunesis Pharmaceuticals Acute Myeloid Leukemia Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Industry Market Size
